Morepen Laboratories Surges 7.28%, Outperforms Sector and Sensex in Stock Market
Morepen Laboratories, a midcap pharmaceutical company, has seen a surge in its stock price, gaining 7.28% on September 9th and closing at Rs 95.4. The stock is currently trading close to its 52-week high and has outperformed the sector by 6.65%. Despite high volatility, it has maintained its position above key moving averages, making it a promising stock for investors.
Morepen Laboratories, a midcap pharmaceutical company, has been making headlines in the stock market with its recent surge in stock price. On September 9th, the company's stock gained 7.28%, closing at Rs 95.4. This positive performance has caught the attention of investors and market experts, with MarketsMOJO giving a 'Buy' call for the stock.
The stock is currently trading close to its 52-week high of Rs 96.6, showing a strong upward trend. Morepen Laboratories has also outperformed the pharmaceutical and drugs sector by 6.65% today, indicating a strong market sentiment towards the company.
The stock has shown high volatility today, with an intraday volatility of 6.26%. However, it has managed to maintain its position above the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive sign for investors.
In comparison to the Sensex, Morepen Laboratories has outperformed with a 1-day performance of 7.29% against the Sensex's 0.18%. The company has also shown a strong 1-month performance of 64.89%, while the Sensex has only seen a 2.03% increase.
With its consistent positive performance and strong market sentiment, Morepen Laboratories is definitely a stock to watch out for in the pharmaceutical and drugs industry. Investors can consider adding this midcap company to their portfolio for potential growth and returns.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
